Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Finding function in novel targets: C. elegans as a model organism.

Titus Kaletta1, Michael O Hengartner

  • 1Devgen, Technologie-park 30, B-9052 Gent, Belgium. titus.kaletta@devgen.com

Nature Reviews. Drug Discovery
|May 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apoptotic cell death in disease-Current understanding of the NCCD 2023.

Cell death and differentiation·2023
Same author

MINA-1 and WAGO-4 are part of regulatory network coordinating germ cell death and RNAi in C. elegans.

Cell death and differentiation·2019
Same author

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Cell death and differentiation·2018
Same author

Differential regulation of germ line apoptosis and germ cell differentiation by CPEB family members in C. elegans.

PloS one·2017
Same author

Post-transcriptional control of executioner caspases by RNA-binding proteins.

Genes & development·2016
Same author

Natural Genetic Variation Influences Protein Abundances in C. elegans Developmental Signalling Pathways.

PloS one·2016

The nematode worm Caenorhabditis elegans is a powerful model for biomedical research. Its use accelerates drug target validation and understanding disease mechanisms in vivo.

Area of Science:

  • Biomedical Research
  • Genomics
  • Pharmacology

Background:

  • Caenorhabditis elegans, a simple nematode, serves as a valuable model organism in biomedical research.
  • Its cellular complexity and conserved disease pathways facilitate studies relevant to higher organisms.
  • Genomics technologies have identified numerous novel drug targets.

Approach:

  • Utilizing C. elegans for in vivo high-throughput compound screening.
  • Employing C. elegans for large-scale drug target validation.
  • Leveraging conserved pathways for disease mechanism studies.

Key Points:

  • C. elegans offers a cost-effective and simple cultivation system for research.
  • Its amenability to whole-organism screening aids in drug discovery.

Related Experiment Videos

  • The model aids in functional characterization of drug targets.

    • Conclusions:

    • C. elegans models advance the understanding of molecular mechanisms in drug action.
    • This model organism is crucial for elucidating disease pathogenesis.
    • Its application enhances biomedical research efficiency and scope.